Neonatal infections affect about 7 million neonates causing over 600 000 deaths every year. Estimating the burden is challenging as there are multiple reporting criteria and definitions for serious bacterial infections in neonates. Essential criteria for reporting serious neonatal bacterial infections have recently been published as the STROBE-NI checklist and, in the context of maternal vaccination, definitions have been published by the Brighton Collaboration Global Alignment of Immunization safety Assessment in pregnancy (GAIA) project. Standardisation of reporting criteria is essential to allow data comparability. This an important step in providing a clearer picture of the burden of serious bacterial infections in neonates and a welcome progress for guiding new investments in interventions.
In the neonatal period over 600 000 deaths every year are directly due to infections, with the highest burden in low and middle income countries (LMICs). 1 The burden of clinically defined possible serious bacterial infections in neonates is high. Meta-analyses of studies from sub Saharan Africa, South Asia and Latin America estimate that 6.9 million neonates need treatment for possible serious bacterial infections each year: 2 this is over 3 times the yearly burden of new HIV infections in children under 15 years of age. 3 Neonatal infections and mortality are highest in the first 24 hours after birth and are disproportionally more common in low income countries, where most births occur at home. In these settings capturing the burden of early infections and deaths is logistically challenging, even as part of research studies, because births and deaths are regularly not reported.
Global estimates that specifically reflect aetiology, antimicrobial resistance patterns and outcome have never been possible due limited access to diagnosis and treatment in the highest burden settings, as well as inconsistency of clinical diagnosis. Few countries have adequate surveillance systems for neonatal infection and the burden of impairment after neonatal infection is also not well established. 4 Definitions of serious bacterial infection in neonates vary and there are no universally accepted standards. Underlying this are the challenges of diagnosing serious bacterial infection, which is usually based on simple clinical algorithms due to limited laboratory facilities in LMICs. Even where available, blood cultures are often negative due to small volume samples and frequent contamination. Molecular methods using nucleic-acid extraction are highly sensitive, but bring their own challenges of interpretation and are mostly limited to research settings.
Tables 1, 2 and 3 illustrate the plethora of definitions and reporting criteria used by current neonatal networks and epidemiological units, mostly based in high income countries. Substantial differences in definitions of serious bacterial infections make comparisons between studies difficult, even when raw data are compared, because different indicators are collected. Some definitions and criteria are widely used to inform research studies, but are often adapted to local circumstances rendering the resulting data incomparable.
The variation in clinical definitions and research reporting criteria for neonatal infections is partly due to the existence of a number of types of surveillance networks, which have been designed for different purposes. These include clinical networks monitoring all aspects of neonatal care (e.g. International Neonatal Network, iNEO), networks which focus on infections in (mostly adult) intensive care settings and epidemiological networks such as those coordinated by the US Centers for Disease Control (CDC) and the European Medicine Agency (EMA), which supervises the development and evaluation of new and existing drugs. There are also a limited number of surveillance groups focusing specifically on COMMENTARY Primarily epidemiological and trial units: (E)CDC: (European) centre for disease control (epidemiological purposes); EMA: European medicine agency (providing definitions used in clinical trials); GAIA: global alignment of immunization safety assessment in pregnancy; NHSN: national healthcare safety network (part of CDC tracking health care associated infections). a CNN has several definition criteria, one is listed in the table, the others are as follows: 1. Fever, chills or hypotension (or fever, hypothermia, apnoea or bradycardia) and common skin contaminant isolated from a blood culture in a patient with intravascular access device AND the physician institutes appropriate antimicrobial therapy for at least 5 days; 2. The three clinical signs above and common skin contaminant isolated from patient's blood culture and physician institutes appropriate antimicrobial therapy for at least 5 days; 3. One of the three clinical signs above and positive antigen test on blood and organism is not related to infection in another site. database is a global initiative that aims to monitor and reduce the rate of healthcare associated infections, particularly in LMICs, and includes neonates. 6 Definitions used for hospitalized neonates, especially in high income countries, have limited value for early onset infection in the community or in lower level health care settings with the highest burden of disease. Simpler clinical definitions of serious bacterial infections such as the WHO young infant definition, are available and are essential for clinical decision making in low-resource settings. These have been used in some of the few available population-based studies. However, with wide variations in reporting between studies and different adaptations of the original definitions, it remains extremely challenging to reconcile differences in data for large-scale analysis of burden, aetiology and outcomes after interventions.
Addressing these issues, two recent collaborative projects have made important steps towards improved reporting of neonatal infection data. The Strengthening Publications Reporting Infections in Newborns Globally (SPRING) group was formed in 2015 with the intention of reducing some of the heterogeneity by reaching a consensus on essential reporting criteria for neonatal infection data. The group is an expert panel of clinicians, academics, researchers, epidemiologists, funders and statisticians. Following a systematic literature review, they prepared and disseminated a survey of possible reporting criteria to a large group of experts from 37 countries representing all 5 continents. The reporting criteria were then discussed in a consensus meeting and 28 final items were included in the STROBE-NI (Strengthening the Reporting of Observational Studies in Epidemiology for Neonatal Infection) checklist, published in September 2016. 7 It is hoped that the STROBE-NI criteria will not only improve reporting, but also indirectly shape research and study design. Definitions for neonatal bloodstream infections, meningitis and respiratory infections have been produced by the Brighton Collaboration Global Alignment of Immunization safety Assessment in pregnancy (GAIA) project, aiming to define neonatal infection in the context of maternal vaccine studies. 8 As improving newborn survival gains recognition as a key global health priority, these new international guidelines will be essential in supporting quality research in serious bacterial infections and possible serious bacterial infections, estimates of the burden of disease and for the evaluation of interventions aimed at pregnant women, neonates and infants.
Authors' contributions: SV drafted the manuscript, ACS, EJAF, MS and PTH edited and contributed to successive versions of the manuscript. SV, ACS, EJAF and PTH were involved in the SPRING group and the development of the STROBE-NI guidelines. SV and PTH coordinated the GAIA working group for the definitions of neonatal infections. SV is guarantor of the paper.
